Neuraxis (NRXS) 10% owner Brian Hannasch adds 80,000 shares

Rhea-AI Filing Summary

Neuraxis, Inc. 10% owner Brian P. Hannasch reported open-market purchases of the company’s common stock. He bought 40,000 shares on February 11, 2026 at a weighted average price of $4.65 per share and another 40,000 shares on February 12, 2026 at a weighted average price of $4.92 per share. Following these transactions, he directly beneficially owned 1,211,522 shares of Neuraxis common stock.

Insider Trade Summary

Net Buyer: 80,000 shares ($382,800)

Net Buy 2 txns

Insider Hannasch Brian

Role 10% Owner

Bought 80,000 shs ($383K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	40,000	$4.92	$197K
Purchase	Common Stock	40,000	$4.65	$186K

Holdings After Transaction: Common Stock — 1,211,522 shares (Direct)

Footnotes (1)

1. Reflects the weighted average price of 40,000 shares of common stock of Neuraxis, Inc. purchased by the reporting person in multiple transactions on February 11, 2026 with purchase prices ranging from $4.53 to $4.85 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Reflects the weighted average price of 40,000 shares of common stock of Neuraxis, Inc. purchased by the reporting person in multiple transactions on February 12, 2026 with purchase prices ranging from $4.70 to $4.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hannasch Brian

(Last) (First) (Middle)

8815 W. STATE ROAD 46

(Street)

COLUMBUS IN 47201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		P		40,000	A	$4.65(1)	1,171,522	D
Common Stock	02/12/2026		P		40,000	A	$4.92(2)	1,211,522	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average price of 40,000 shares of common stock of Neuraxis, Inc. purchased by the reporting person in multiple transactions on February 11, 2026 with purchase prices ranging from $4.53 to $4.85 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

2. Reflects the weighted average price of 40,000 shares of common stock of Neuraxis, Inc. purchased by the reporting person in multiple transactions on February 12, 2026 with purchase prices ranging from $4.70 to $4.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

	/s/ Griffin D. Foster, Attorney-in-Fact for Brian P. Hannasch	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Neuraxis (NRXS) report in this Form 4?

Neuraxis reported open-market insider stock purchases. 10% owner Brian P. Hannasch bought 40,000 Neuraxis common shares on February 11, 2026 and another 40,000 shares on February 12, 2026, as disclosed in this Form 4 filing.

How many Neuraxis (NRXS) shares did Brian Hannasch buy and at what prices?

Brian P. Hannasch purchased 80,000 Neuraxis shares in total. He bought 40,000 shares at a weighted average price of $4.65 on February 11, 2026 and 40,000 shares at a weighted average price of $4.92 on February 12, 2026.

How many Neuraxis (NRXS) shares does Brian Hannasch own after these transactions?

After the reported purchases, Hannasch owned 1,211,522 shares. The Form 4 shows his directly beneficially owned Neuraxis common stock increased to 1,211,522 shares following the February 12, 2026 open-market transaction.

What does the transaction code “P” mean in the Neuraxis (NRXS) Form 4?

The transaction code “P” indicates an open-market purchase. In this Form 4, code P is used for Brian P. Hannasch’s acquisitions of Neuraxis common stock through open-market or private purchase transactions on February 11 and 12, 2026.

Is the Neuraxis (NRXS) insider transaction direct or indirect ownership?

The reported Neuraxis insider ownership is direct. The Form 4 lists ownership type as “D” for direct, meaning the 1,211,522 Neuraxis common shares following the transactions are directly beneficially owned by Brian P. Hannasch.

Were the Neuraxis (NRXS) insider purchases made in single trades or multiple trades?

The insider purchases were executed in multiple trades. Footnotes state each 40,000-share block reflects a weighted average price across several trades within price ranges on February 11 and February 12, 2026.